Full Text View
Tabular View
No Study Results Posted
Related Studies
Analysis of the Potentially Parasitocidal Effect of a Long Term Chemotherapy With Benzimidazoles
This study is currently recruiting participants.
Verified by University of Zurich, April 2008
First Received: April 8, 2008   Last Updated: April 11, 2008   History of Changes
Sponsor: University of Zurich
Information provided by: University of Zurich
ClinicalTrials.gov Identifier: NCT00658294
  Purpose

The aim of this study is to evaluate PET-CT and EmII/3-10 serology as potential markers to assess the parasitocidal effect of benzimidazoles

  • Trial with medicinal product

Condition Intervention Phase
Alveolar Echinococcosis
 Other: Stop treatment
 Phase IV

Study Type: Observational
Study Design: Cohort, Prospective
Official Title: Analysis of the Potentially Parasitocidal Effect of a Long Term Chemotherapy With Benzimidazoles in Patients With Inoperable Alveolar Echinococcosis Using PET-CT and EmII/3-10 Serology

Further study details as provided by University of Zurich:

Biospecimen Retention:   None Retained

Biospecimen Description:

Estimated Enrollment: 30
Study Start Date: January 2008
Estimated Study Completion Date: January 2009
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Study Population

Patients with inoperable alveolar echinococchosis

Criteria

Inclusion criteria:

  • Patients with inoperable alveolar echinococcosis
  • With negative PET-CT
  • EmII/3-10 serology under long-term chemotherapy with benzimidazoles

Exclusion criteria:

  • Positive PET-CT
  • Positive EmII-3-10 Serology
  • No compliance
  • Reduced life expectancy
  • Pregnancy
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00658294

Contacts
Contact: 01 Studienregister MasterAdmins 41-044-255-1111

Locations
Switzerland
University Hospital Zurich Recruiting
Zurich, Switzerland
Contact         Beat.Müllhaupt@usz.ch    
Contact         Beat.Müllhaupt@usz.ch    
Sponsors and Collaborators
University of Zurich
Investigators
Principal Investigator: Beat Müllhaupt 01 Studienregister MasterAdmins UniversitaetsSpital Zuerich
  More Information

No publications provided

Responsible Party: University Hospital Zurich ( Beat Müllhaupt )
Study ID Numbers: EK-1351
Study First Received: April 8, 2008
Last Updated: April 11, 2008
ClinicalTrials.gov Identifier: NCT00658294     History of Changes
Health Authority: Switzerland: Swissmedic

Additional relevant MeSH terms:
Anti-Infective Agents
Liver Diseases
Anthelmintics
Benzimidazole
Pharmacologic Actions
Echinococcosis
Liver Diseases, Parasitic
 Antiparasitic Agents
Digestive System Diseases
Echinococcosis, Hepatic
Therapeutic Uses
Parasitic Diseases
Cestode Infections
Helminthiasis

ClinicalTrials.gov processed this record on November 30, 2009



Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services